These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 33248006
1. Three types of cataract associated with atopic dermatitis and chronic topical corticosteroid use: A case report. Ruiz-Lozano RE, Hernandez-Camarena JC, Roman-Zamudio M, Alcazar-Félix RJ, Davila-Cavazos O, Cardenas-de la Garza JA. Dermatol Ther; 2021 Jan; 34(1):e14600. PubMed ID: 33248006 [No Abstract] [Full Text] [Related]
2. Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataracts. Haeck IM, Rouwen TJ, Timmer-de Mik L, de Bruin-Weller MS, Bruijnzeel-Koomen CA. J Am Acad Dermatol; 2011 Feb; 64(2):275-81. PubMed ID: 21122943 [Abstract] [Full Text] [Related]
3. [Atopic eczema]. van der Waal RI. Ned Tijdschr Tandheelkd; 2010 Dec; 117(12):609. PubMed ID: 21302373 [No Abstract] [Full Text] [Related]
4. Assessing the relationship between topical corticosteroid phobia and susceptibility to misinformation in patients with atopic dermatitis. Hrin ML, Bray JK, Fleischer AB, Feldman SR. J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e115-e118. PubMed ID: 34534378 [No Abstract] [Full Text] [Related]
5. Cataract and retinal detachment in patients with severe atopic dermatitis who were withdrawn from the use of topical corticosteroid. Taniguchi H, Ohki O, Yokozeki H, Katayama I, Tanaka A, Kiyosawa M, Nishioka K. J Dermatol; 1999 Oct; 26(10):658-65. PubMed ID: 10554432 [Abstract] [Full Text] [Related]
7. Topical corticosteroid phobia in patients with atopic eczema. Charman CR, Morris AD, Williams HC. Br J Dermatol; 2000 May; 142(5):931-6. PubMed ID: 10809850 [Abstract] [Full Text] [Related]
8. Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation. Green C, Colquitt JL, Kirby J, Davidson P, Payne E. Health Technol Assess; 2004 Nov; 8(47):iii,iv, 1-120. PubMed ID: 15527669 [Abstract] [Full Text] [Related]
9. NICE guidance on use of topical corticosteroids in atopic eczema. Radley K. Nurs Times; 2004 Nov; 100(38):26-7. PubMed ID: 15493760 [Abstract] [Full Text] [Related]
10. Acute irreversible corticol cataracts in prolonged topical corticosteriod overuse for chronic eczema. Sim DA, Chen RP, Hove M, Verma S. Eye (Lond); 2009 Apr; 23(4):984. PubMed ID: 18437177 [No Abstract] [Full Text] [Related]
11. Association between topical corticosteroid use and fracture risk among pediatric patients with atopic dermatitis. Imhof RL, Weaver AL, St Sauver J, Hand J, Davis DMR, Tollefson MM. J Am Acad Dermatol; 2022 Aug; 87(2):409-411. PubMed ID: 34428532 [No Abstract] [Full Text] [Related]
12. Adrenal axis suppression caused by a small dose of a potent topical corticosteroid. Miyachi Y. Arch Dermatol; 1982 Jul; 118(7):451-2. PubMed ID: 7092266 [No Abstract] [Full Text] [Related]
13. [The use of topical corticosteroids in atopic dermatitis in children]. Cambazard F. Ann Dermatol Venereol; 2005 Jan; 132 Spec No 1():1S64-7. PubMed ID: 15984295 [Abstract] [Full Text] [Related]
14. [The practice guideline 'atopic dermatitis']. Bruijnzeel-Koomen CA, Sillevis Smitt JH, Boukes FS, van Everdingen JJ. Ned Tijdschr Geneeskd; 2007 Jun 23; 151(25):1399-402. PubMed ID: 17668603 [Abstract] [Full Text] [Related]
15. Tape-strips provide a minimally invasive approach to track therapeutic response to topical corticosteroids in atopic dermatitis patients. Olesen CM, Pavel AB, Wu J, Mikhaylov D, Del Duca E, Estrada Y, Krueger JG, Zhang N, Clausen ML, Agner T, Guttman-Yassky E. J Allergy Clin Immunol Pract; 2021 Jan 23; 9(1):576-579.e3. PubMed ID: 32889222 [No Abstract] [Full Text] [Related]
18. Rebound vasodilation from long-term topical corticosteroid use. Rapaport M. Arch Dermatol; 2007 Feb 23; 143(2):268-9. PubMed ID: 17310013 [No Abstract] [Full Text] [Related]
19. Atopic eczema in children. Hoey J. CMAJ; 2002 Jun 25; 166(13):1694. PubMed ID: 12126329 [No Abstract] [Full Text] [Related]
20. [CLINICAL PRACTICE GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS: SOME POINTS IN THE TREATMENT WITH TOPICAL CORTICOSTEROIDS]. Katoh N. Arerugi; 2019 Jun 25; 68(9):1111-1114. PubMed ID: 31723106 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]